Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03439319Not ApplicableCompleted

Restoration of Reaching and Grasping Function in Individuals With Spinal Cord Injury Using MyndMove® Neuromodulation Therapy

Role: lead

NCT02266836Not ApplicableCompleted

MyndMove Therapy for Severe Hemiparesis of the Upper Limb Following Stroke

Role: lead

NCT02799966Not ApplicableTerminated

Recovery of Upper Limb Function in Persons With Spinal Cord Injury: Lead-In Study

Role: collaborator

NCT03147794Not ApplicableUnknown

Functional Electrical Stimulation for Children With Upper Limb Weakness Post Stroke

Role: collaborator

All 4 trials loaded